Radioisotopes for medicine
NPI CAS has also a long term experience with research of medical radionuclides and investigation of labeled compounds as potential radiopharmaceuticals. As this program is being started in SPIRAL2, we enter the collaborative efforts and we plan to contribute with our technical and chemical know how to development of a specialized target for R&D.
The radiopharmaceutical target development will allow (after 2018) to study the production techiques on thick target with high current beams.
The target for medical isotopes will serve to test the production of the radioisotopes and will enable to join the collaboration with the other partners.
The target will be designed and developed in NPI CAS Rez in 2018.